Measles and rubella vaccine arrives in Kyrgyzstan to help stop measles outbreak
Pandemic Influenza Preparedness (PIP) Framework
African vaccine manufacturing capacity – Africa CDC
Vulnerable? Vaccinate. Protecting the unprotected from COVID-19 and influenza
London at risk of measles outbreaks with modelling estimating tens of thousands of cases
Bringing mpox vaccination, health advice and care closer to people living with HIV in France: spotlight on the work of AIDES
Diagnostics laboratory emergency use listing
Donors making a difference: building stronger health systems
MMWR Weekly COVID-19 Briefing
18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF
Reduced Odds of Mpox-Associated Hospitalization...
Stopping an Outbreak: Polio Response in Mozambique
All secondary school pupils eligible for free flu vaccine
Africa CDC Renews its Commitment to Reduce Vaccine-Preventable Diseases and Outbreaks in Africa – Africa CDC
Pilot protocol for influenza vaccine effectiveness against laboratory-confirmed influenza infections (symptomatic) using healthcare worker cohorts
2023-2024 CDC Flu Vaccination Recommendations Adopted
Novel vaccines may help quell polio outbreaks
Progress Toward Rubella Elimination — World Health ...
HPV vaccination programme moves to single dose from September 2023
Safety Information for Diphtheria, Tetanus, and Pertussis Vaccines | Vaccine Safety | CDC
The Mass COVID-19 vaccination Campaign in the Democratic Republic of Congo reaches over 300,000 people – Africa CDC
Guidance on Operational Microplanning for COVID-19 Vaccination
Focus on unvaccinated children, strengthen routine immunization capacities: WHO
Protective measures and options for public health response for avian influenza
NAM President Victor Dzau Emphasizes Sustainable Regional Vaccine Manufacturing for Global Health Security - National Academy of Medicine
ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants
Guidance on operational microplanning for COVID-19 vaccination, revised 2 May 2023
Global Compendium of Knowledge on COVID-19
Autumn vaccination campaigns focused on older age groups and other high-risk populations are key to decrease impact of COVID-19
The role of communities in cholera vaccination campaigns
COVID-19 vaccination is rising in many vulnerable African communities thanks to EU-funded, WHO-led project
Recommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza season
EPI-WIN webinar: Influenza vaccines: what makes them work
Protecting infants through covid-19 vaccination during pregnancy
Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers - Repository - Public Health Scotland
International Pandemic Preparedness Secretariat Releases New Report; NAM President Victor Dzau Co-Chairs IPPS Scientific Advisory Group - National Academy of Medicine
Benefits of Flu Vaccination During 2021-2022 Flu Season
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratory-confirmed with SARS-CoV-2 or with seasonal influenza - Version 2.0
Protocol for a COVID-19 vaccine effectiveness study using health data registries
Early Estimates of Bivalent mRNA Booster Dose Vaccine ...
Covid-19: Vaccination plus infection offers best protection, finds study led by WHO
Reasons for Receiving or Not Receiving Bivalent COVID ...
COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
Experimental HIV vaccine regimen safe but ineffective, study finds
Vaccination - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
WHO announces plans to establish a TB Vaccine Accelerator Council
Circulating vaccine-derived poliovirus type 2 (cVDPV2) – Sudan
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
Poliovirus Containment
Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021
Flu Vaccination Coverage Update
Developing mucosal vaccines for respiratory viruses
Outliving the virus: various reasons for COVID-19 vaccination
Varicella vaccine (live): PGD template
Protecting the workforce through influenza and COVID-19 vaccination: perspectives from Greece
Advisory group urges countries to prioritize protecting the most vulnerable with COVID-19 vaccination and integrate COVID-19 vaccination into routine health-care strategies
Flu Vaccine Uptake in Caregivers and Noncaregivers: Implications for Policy and Practice
Racial and Ethnic Differences in COVID-19 Vaccination Coverage Among Children and Adolescents Aged 5–17 Years and Parental Intent to Vaccinate Their Children — National Immunization Survey–Child COVID Module, United States, December 2020–September 2022
COVID-19 vaccine for children after MIS-C appears safe
The Mpox Vaccine (JYNNEOS Vaccine) | Monkeypox | Poxvirus | CDC
Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022 | MMWR
Health workers in North Macedonia urge vulnerable people: get vaccinated against seasonal influenza
Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)
Malaria vaccine implementation programme
U.S. CDC in Uganda and Partners Bring COVID-19 Vaccines to Local Populations | CDC
Gift yourself a life-saving vaccine this Christmas holiday
Benefits of Flu Vaccination During 2019-2020 Flu Season
Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection
Flu Vaccine Effectiveness Networks
Nursing Home COVID-19 Vaccination Data Dashboard | NHSN | CDC
Regulatory approval of COVID-19 vaccine VidPrevtyn Beta
Sanofi Pasteur COVID-19 vaccine authorised by MHRA
WHO Information Meeting on the Composition of Influenza Virus Vaccines for Use in the 2023-2024 Northern Hemisphere Influenza Season
Diphtheria - Vaccine Preventable Diseases Surveillance Manual | CDC
Ebola vaccine regimens safe, immunogenic in adults and children
North Macedonia's caravan: bringing COVID-19 vaccines and information about influenza and other vaccines to communities
Long Term Care Facilities Enrolling in CDC COVID-19 Vaccination Program | CDC
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
SAVE THE DATE: Sudan Ebolavirus Candidate Vaccines - What additional research should be conducted to advance the evaluation of these vaccines?
CDC Expands Updated COVID-19 Vaccines to Include Children Ages 6 Months through 5 Years
Pneumococcal disease infections caused by serotypes not in Prevenar 13 vaccine
Last updated 12/2022 - Summary of Product Characteristics Comirnaty 3 micrograms/dose concentrate for ages 6 months to 4 years (maroon cap)
Pregnant People Hit Hard By Flu But Many Remain Unvaccinated
Ebola trial candidate vaccines arrive in Uganda in record 79 days after outbreak declared
ECDC and EMA collaborate on vaccine safety and effectiveness monitoring studies
Episode #87 - Is Measles making a comeback
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
Mpox Vaccination Program Provider Agreement
In Denmark, people roll up their sleeves for seasonal influenza and COVID-19 vaccines
Using mRNA technology for a universal flu vaccine
Experimental mRNA Vaccine May Protect Against All 20 Influenza Virus Subtypes
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - December 2022
Diphtheria treatment and vaccination simple text guide
Vaccine Glossary of Terms | CDC
Getting vaccines to those who need them most: Albania launches autumn influenza campaign and begins to roll out COVID-19 booster doses
POD Assist Features and Benefits
The Republic of Korea to Donate First Batch of Mpox Vaccine to Africa – Africa CDC
Organization Gets Community Members to Play Key Role in Getting People Vaccinated | CDC
Concern over low rate of 2 to 3 year olds getting the flu vaccine
Women leaders in North Macedonia build trust in COVID-19 vaccination
Eligible people urged to get vaccinated as flu season officially under way
Monkeypox vaccines technical documents
Monkeypox: Single dose of smallpox vaccine offers 78% protection, UKHSA reports
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
UKHSA finds vaccination offers strong protection against monkeypox
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0
The flu jab in pregnancy
Sociodemographic Variation in Early Uptake of COVID-19 Vaccine ..
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of ..
Background document for the SAGE October 2022 session on monkeypox vaccines
WHO Vaccine Prioritization Working Group. Summary of the evaluations and recommendations on the three Sudan ebolavirus vaccines that are candidates for inclusion in the planned ring vaccination trial in Uganda ("Tokomeza Ebola)
COVID-19 Vaccine Delivery Partnership - October 2022
CDC South Africa supports vaccination against COVID-19 | CDC
Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms | BMJ
The Africa Union COVID-19 Vaccination BINGWA Initiative | Africa CDC initiative to speed and scale up COVID-19 vaccination in Africa – Africa CDC
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
New Study Shows Benefits of Flu Vaccination During Pregnancy
Vaccine access: World's poorest people suffer at the hands of free market dynamics, says WHO
Global Vaccine Market Report 2022
Advancements in Influenza Vaccines
United States Provides Pediatric Pfizer Vaccines to Protect Children from COVID-19
Routine Vaccination Coverage — Worldwide, 2021
Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season — Chile, 2022 | MMWR
Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival — Louisiana, August 9–September 5, 2022 | MMWR
CDC and Tanzania Speed Up COVID-19 Vaccinations | CDC
Getting a Flu Vaccine and a COVID-19 Vaccine at the Same Time | CDC
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
World Polio Day 2022: Joint statement by Commissioners Stella Kyriakides, Jutta Urpilainen, and Director of ECDC Dr Andrea Ammon
Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Monkeypox Outbreak | Monkeypox | Poxvirus | CDC
A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events — Georgia, August 27–September 5, 2022 | MMWR
Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022 | MMWR
Cholera: WHO rations vaccines to preserve stocks amid rising outbreaks | The BMJ
Call for Applications: African Union (AU) COVID-19 Vaccination Bingwa Initiative – Eastern Africa Region – Africa CDC
Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 | MMWR
Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022 | MMWR
Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2021–22 | MMWR
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 | MMWR
Management and safe disposal of COVID-19 vaccination waste at health facility level
Shortage of cholera vaccines leads to temporary suspension of two-dose strategy, as cases rise worldwide
COVID-19 vaccination: a guide on pregnancy and breastfeeding - GOV.UK
Flu Vaccination Coverage, United States, 2021–22 Influenza Season | FluVaxView | Seasonal Influenza (Flu) | CDC
Inequities in Flu Vaccine Uptake | VitalSigns | CDC
Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity—United States, 2009–10 Through 2021–22 Influenza Seasons | MMWR
Covid-19: Booster vaccines rolled out as hospital admissions rise | The BMJ
USAID Provides $1.5 Million for COVID-19 Vaccine Rollout Support in Lao PDR
Building COVID-19 Vaccine Confidence in Minnesota's Prisons and Jails | CDC
Ad Council, AMA, and CDC Urge Flu Vaccinations with "Get My Flu Shot" Campaign
Donors making a difference: The European Union teams up with WHO to boost COVID-19 vaccination coverage in Africa
Joint statement: Working together towards COVID-19 and seasonal influenza vaccinations for this winter
Community leaders in Georgia called upon to promote COVID-19 vaccination
Vaccine-preventable disease update: reported diphtheria cases in the WHO European Region, 2022: 10 October 2022
National flu immunisation programme 2022 to 2023 letter - GOV.UK
Safety Information for Monkeypox Vaccine | Vaccine Safety | CDC
Learning lessons from the pilots: overcoming knowledge gaps around the malaria vaccine schedule in support of vaccine uptake
WHO Director-General's opening remarks at the media briefing – 5 October 2022
Flu vaccination guidance for Personal Assistants (PAs) - GOV.UK
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022 | MMWR
Fight Flu – Don't Let it Stop You | CDC
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022 | MMWR
UK childhood vaccination rates fell last year in almost all programmes, figures show | The BMJ
Rates of Monkeypox Cases by Vaccination Status | Monkeypox | Poxvirus | CDC
Parents are urged to vaccinate 2-3 year olds against flu as NHS warns of "twindemic" | The BMJ
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
‘Foreign disinformation' social media campaigns linked to falling vaccination rates | BMJ
JCVI statement on vaccine dose prioritisation in response to the monkeypox outbreak - GOV.UK
Safety and side effects - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland
Second vaccine doses to be offered to those at highest risk from monkeypox - GOV.UK
Monkeypox Vaccine Equity Toolkit | Monkeypox | Poxvirus | CDC
4. A(H3N2) - Cell culture-derived - Southern Hemisphere 2023
New recommendations for the composition of influenza vaccines in 2023 for the southern hemisphere
No time for COVID-19 complacency, say key countries responsible for tracking global rollout of COVID-19 vaccines, tests and treatments
National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine - GOV.UK
Global vaccine safety blueprint 2.0 (GVSB2.0) 2021-2023
Reporting Adverse Events Following Vaccination | Vaccine Safety | CDC
400 000 doses of Comirnaty vaccine delivered to Ukraine under COVAX
Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries
Seasonal Influenza Vaccine Safety: A Summary for Clinicians | CDC
Flu Vaccine Safety and Pregnancy | CDC
Monkeypox Vaccine Administration U.S. Map | Monkeypox | Poxvirus | CDC
Monkeypox Vaccine Equity Pilot Program | Monkeypox | Poxvirus | CDC
Malaria vaccines: preferred product characteristics and clinical development considerations
A guide to the COVID-19 autumn booster - GOV.UK
WHO policy brief: Reaching COVID-19 vaccination targets, 14 September 2022
FAQs on Reporting COVID-19 Vaccination Data | NHSN | CDC
The government guarantees PCV immunization for all Indonesian children to protect them from the dangers of pulmonary inflammation (pneumonia)
Ireland tracks its way to COVID-19 vaccine delivery success
Novavax COVID-19 vaccine Nuvaxovid approved by MHRA - GOV.UK
Eligible groups - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland
Clinical Trial Evaluating Monkeypox Vaccine Begins | National Institutes of Health (NIH)
Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years — PROTECT Cohort, Four States, July 2021–May 2022 | MMWR
COVID-19: recommendations on use of adapted vaccines
Africa CDC and Partners mobilize National EPI Managers and other Stakeholders to accelerate COVID-19 vaccination in Africa. – Africa CDC
Regulatory approval of Pfizer/BioNTech bivalent Original/Omicron booster vaccine - GOV.UK
4 Vaccine Distribution and Delivery | Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines |The National Academies Press
Cell-Based Flu Vaccines | CDC
US and Canada to roll out the first omicron specific boosters within days | The BMJ
CDC Recommends the First Updated COVID-19 Booster | CDC Online Newsroom | CDC
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR
Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years — United States, August 13, 2021–August 5, 2022 | MMWR
Flu Vaccination by Jet Injector | CDC
Monkeypox Vaccination Basics | Monkeypox | Poxvirus | CDC
COVID-19 vaccination programme - GOV.UK
Health authorities working with community stakeholders to control Monkeypox in Portugal
Weekly epidemiological record, 2022, vol. 97, 34 (full issue)
Seasonal Influenza Vaccine Supply for the U.S. 2022-2023 Influenza Season | CDC
Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2022-23’
Adjuvanted Flu Vaccine | CDC
Influenza (Flu) Vaccine Safety | CDC
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season | MMWR
Inadvertent vaccination in pregnancy (VIP) - GOV.UK
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF
EpiData, 2/2022
Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA
Monkeypox: Fractional vaccine doses will be piloted as new treatment trial launches | The BMJ
WHO, EU support the Philippines' vaccine information system
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
100 000 doses of the Janssen vaccine delivered to Ukraine under COVAX
Background document on the Valneva VLA2001 vaccine against COVID-19
CDC Recommends Novavax COVID-19 Vaccine for Adolescents | CDC Online Newsroom | CDC
Vaccines and immunization for monkeypox: Interim guidance, 24 August 2022
African Union COVID-19 Vaccination Bingwa Initiative – Africa CDC
Monkeypox Vaccination Program Provider Agreement | Monkeypox | Poxvirus | CDC
Progress Toward Measles Elimination — South-East Asia Region, 2003–2020 | MMWR
Immunization in Canada: Canadian Immunization Guide - Canada.ca
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 | MMWR
Monkeypox: UK to run out of vaccine doses by next week | The BMJ
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19
Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme | The BMJ
Fighting current and future coronaviruses with a single vaccine | National Institutes of Health (NIH)
Winter vaccine resources for healthcare workers - Publications - Public Health Scotland
COVID-19: Effectiveness and benefits of vaccination - Canada.ca
Update on vaccination to protect against monkeypox in England - GOV.UK
JCVI publishes advice on COVID-19 vaccines for autumn booster programme - GOV.UK
Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy | The BMJ
Polio Vaccination Recommendations for Specific Groups | CDC
Benefits of Getting A COVID-19 Vaccine | CDC
Polio vaccine is offered to all children in London aged 1 to 9 after virus detected in sewage | The BMJ
Polio Vaccine Composition, Dosage, Administration, and Administration Errors | CDC
Polio booster campaign resources - GOV.UK
All children aged 1 to 9 in London to be offered a dose of polio vaccine - GOV.UK
Interim statement on COVID-19 vaccination for children
Inactivated polio vaccine (IPV) booster: information for healthcare practitioners - GOV.UK
Polio vaccination campaign letter - GOV.UK
Vaccination Administration Considerations for Specific Populations | Monkeypox | Poxvirus | CDC
Vaccination Strategies | Monkeypox | Poxvirus | CDC
JYNNEOS Vaccine | Monkeypox | Poxvirus | CDC
ACAM2000 Vaccine | Monkeypox | Poxvirus | CDC
COVID-19 vaccine guide for youth and adults: Managing COVID-19 vaccine administration errors or deviations - Canada.ca
Advisory Committee on Immunization Practices (ACIP) Work Groups | CDC
Monkeypox: Concerns mount over vaccine inequity | The BMJ
Janssen Jcovden® (Johnson & Johnson) COVID-19 vaccine - Canada.ca
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022 | MMWR
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Novavax COVID-19 Vaccine
Supporting the deployment of COVID-19 vaccines and routine vaccination systems in the Eastern Partnership: Armenia
Summary of Product Characteristics for Vaxzevria - GOV.UK
Vaccine Effectiveness: How Well Do Flu Vaccines Work? | CDC
Reporting form for AEFI
Who Should and Who Should NOT Get a Flu Vaccine | CDC
WHO Consultation on the Composition of Influenza Virus Vaccines for Use in the 2023 Southern Hemisphere Influenza Season
Advisory Committee on Immunization Practices (ACIP) | NCIRD | CDC
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
GRADE: Moderna COVID-19 Vaccine for Persons Aged 12-17 Years | CDC
GRADE: Moderna COVID-19 Vaccine for Children Aged 6-11 Years | CDC
ACIP Evidence to Recommendations for Use of Moderna COVID-19 Vaccine in Children Ages 6 – 17 Years under an Emergency Use Authorization | CDC
Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine in England | The BMJ
Clinical Considerations for Monkeypox in People Who are Pregnant or Breastfeeding | Monkeypox | Poxvirus | CDC
Considerations for Monkeypox Vaccination | Monkeypox | Poxvirus | CDC
Monkeypox outbreak: vaccination strategy - GOV.UK
Monkeypox vaccine to be offered more widely to help control outbreak - GOV.UK
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
ACIP Evidence to Recommendations for Use of JYNNEOS (orthopoxvirus) Vaccine Primary Series for Research, Clinical Laboratory, and Response Team Personnel (Policy Question 1) | CDC
Monkeypox vaccination - GOV.UK
New study updates evidence on rare heart condition after covid vaccination | BMJ
Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials | The BMJ
Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack of demand | The BMJ
Covid-19: GPs are asked to opt into next vaccination phase this autumn | The BMJ
Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s | The BMJ
Covid-19: Second boosters may benefit at-risk groups but have "minimal" impact for others, says WHO | The BMJ
Covid-19: JCVI advises further booster for vulnerable adults and health and care workers | The BMJ
We need to increase MMR uptake urgently | BMJ
Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds | The BMJ
Quadrivalent Influenza Vaccine | CDC
Non-clinical evaluation of vaccines
Vaccine resources in other languages and alternative formats - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland
Appendix A: groups included in the national influenza immunisation programme - GOV.UK
Guiding the evaluation of COVID-19 vaccine effectiveness
Africa CDC Saving Lives and Livelihoods Initiative Commences Implementation in Kenya – Africa CDC
Regional Workshop to Review Progress towards Measles-Rubella and Other Priority VPD Surveillance and Outbreak Preparedness and Response
Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update
Fourth Regional workshop to review progress towards measles-rubella and other priority VPD surveillance and outbreak preparedness and response in WHO South-East Asia region
Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season | MMWR
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States
Statement from NIH and BARDA on the Novavax COVID-19 Vaccine | National Institutes of Health (NIH)
WHO/BS/2022.2432: Report on the WHO collaborative study to establish Universal Reagents for the D-Antigen potency testing of Inactivated Polio Vaccines
MI4A 2022 Public Database
MI4A 2022 Vaccine Product List
COVID-19 Vaccines for Long-term Care Residents | CDC
CDC Recommends Novavax's COVID-19 Vaccine for Adults | CDC Online Newsroom | CDC
Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | National Institutes of Health (NIH)
WHO/BS/2022.2438: Report on the WHO collaborative study to investigate the utility of next generation sequencing (NGS) as a molecular test of virus stocks used in the manufacture of Type 1 and 2 Poliovirus vaccine (Oral)
Free vaccinations for Ukrainian refugees in the Republic of Moldova
ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year
Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022
Key Facts About Seasonal Flu Vaccine | CDC
Greater efforts needed to get routine immunization back to pre-COVID-19 times: WHO
Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses | CDC Online Newsroom | CDC
European Region averts further backsliding in routine immunization but falls short of full recovery
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 | MMWR
Over 50s to be offered COVID-19 booster and flu jab this autumn - GOV.UK
Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age - Canada.ca
COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 | MMWR
WHO/UNICEF Immunization Coverage Estimates - 2021 revision
Moderna Spikevax COVID-19 vaccine - Canada.ca
Input to the WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)
FAQ: COVID-19 Vaccine - Canada.ca
Interim recommendations on COVID-19 vaccination in autumn 2022 for the WHO European Region: conclusions and recommendations of the European Technical Advisory Group of Experts on Immunization
Patient Information Leaflet for COVID-19 Vaccine Valneva - GOV.UK
Expert advisory group recommends COVID-19 vaccination strategy for the autumn season
Bacterial vaccines in clinical and preclinical development 2021
Protect your child against flu – information for parents and carers - GOV.UK
Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR
NIH launches clinical trial of mRNA Nipah virus vaccine | National Institutes of Health (NIH)
Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines
ECDC and EMA update recommendations on additional booster doses of COVID-19 vaccines
COVID-19 Scientific and Public Health Policy Update – (06 July 2022) – Africa CDC
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy - ISS
COVID-19 Vaccine Access in Long-term Care Settings | CDC
Moderna COVID-19 Vaccine's Reactions and Adverse Events | CDC
How Jurisdictions Can Ensure COVID-19 Vaccine Access for Staff and Residents in Long-term Care Settings | CDC
Recombinant Influenza (Flu) Vaccine | CDC
Poliomyelitis
Catalonia ensures COVID-19 vaccine interventions leave no community behind
Influenza Vaccination: A Summary for Clinicians | CDC
Vaccine hesitancy
Fluzone High-Dose Seasonal Influenza Vaccine | CDC
Vaccine update: issue 330, June 2022, COVID-19 spring special edition - GOV.UK
COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 1, 2021–April 25, 2022 | MMWR
Reaching the unreached with COVID-19 vaccination across the Western Pacific Region
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022 | MMWR
Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Publications - Public Health Scotland
Trial of potential universal flu vaccine opens at NIH Clinical Center | National Institutes of Health (NIH)
Multi-year Planning for Oral Cholera Vaccines Needed to Inform Global Vaccine Supply and Help Prevent Deadly Outbreaks
CDC Recommends Moderna COVID-19 Vaccine for Children and Adolescents | CDC Online Newsroom | CDC
ACIP Flu Meeting Update: Flu Vaccines Worked Better than Reported & ACIP Recommends Specific Vaccines For Seniors
COVID-19 Vaccination – Africa CDC
ACT-Accelerator: Quarterly Update Q1: 1 January – 31 March 2022
Understanding Viral Vector COVID-19 Vaccines | CDC
Ways Health Departments Can Help Increase COVID-19 Vaccinations | CDC
COVID-19 vaccines and medicines: updates for June 2022 - GOV.UK
SIREN study - GOV.UK
Uptake of spring booster encouraged as COVID-19 cases rise across Scotland - News - Public Health Scotland
Equity in Childhood COVID-19 Vaccination
COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC
Quick Conversation Guide on COVID-19 Vaccines for Children | CDC
Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines
Interim statement on the composition of current COVID-19 vaccines
Investigation of the vaccine-derived polio virus found in sewage sample in Kolkata
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021 | MMWR
Vaccine Taskforce to merge with UKHSA and OLS - GOV.UK
Suspension of the mandatory vaccination requirement for domestic travellers and federally regulated transportation workers - Canada.ca
Backgrounder: Government of Canada suspends mandatory vaccination for federal employees - Canada.ca
Suspension of the vaccine mandates for domestic travellers, transportation workers and federal employees - Canada.ca
SARS-CoV-2 in children
COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021 | MMWR
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Use of JYNNEOS (orthopoxvirus) vaccine primary series for research, clinical laboratory, response team, and healthcare personnel | CDC
Mobilizing young people to promote vaccination against COVID-19 in the Republic of Moldova
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
COVID-19 vaccine tracker and landscape
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine
Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022
Joint Committee on Vaccination and Immunisation (JCVI) interim statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
COVAX calls for urgent action to close vaccine equity gap
CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | CDC Online Newsroom | CDC
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
JCVI provides interim advice on an autumn COVID-19 booster programme - GOV.UK
WHO validates 11th vaccine for COVID-19
Immunization, Vaccines and Biologicals
Table 3: WHO recommendations for routine immunization
COVID-19: epidemiology, virology and clinical features - GOV.UK
Vaccines against influenza: WHO position paper – May 2022
Introduction to the International Coordinating Group on Vaccine
Coronavirus disease (COVID-19): Vaccines
Global Vaccine Action Plan
Monitoring reports of the effectiveness of COVID-19 vaccination - GOV.UK
National protocol for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant]) - GOV.UK
Africa CDC Releases New Country Research on Scale-Up of COVID Vaccines – Africa CDC
Kyrgyzstan: leveraging SARI surveillance to monitor vaccine effectiveness
Vaccine update: issue 327, May 2022, SCID, TB and BCG special edition - GOV.UK
Pre-exposure Prophylaxis (PrEP) | Prevention | CDC
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
ACIP Evidence to Recommendations for Booster Dose of Rabies Vaccine After the 2-dose Pre-exposure Prophylaxis Schedule | CDC
ACIP Evidence to Recommendations for Rabies Pre-exposure prophylaxis with a 2-dose Schedule | CDC
Ultra-low temperature vaccine management | OpenWHO
COVID-19 vaccine uptake in healthcare workers: explainer - GOV.UK
A second booster could avert a substantial proportion of COVID-19 deaths between now and mid-autumn 2022 in older age groups
Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose
STOP Program
UNICEF and WHO warn of ‘perfect storm' of conditions for measles outbreaks, affecting children
A Safe and Effective Vaccine to Prevent Dengue Is Approved | Division of Vector-Borne Diseases | NCEZID | CDC
Report of the High-Level Ministerial Meeting | Partnerships to Accelerate COVID-19 Vaccination in Africa – Africa CDC
Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine
Solidarity Trial Vaccines
Q&A on RTS,S malaria vaccine
Accelerating COVID-19 Vaccine Deployment
COVID-19 vaccines and medicines: updates for April 2022 - GOV.UK
Over 1 million African children protected by first malaria vaccine
Summary of Product Characteristics Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK
COVID-19: Vaccine safety and side effects - Canada.ca
Circulating vaccine-derived poliovirus type 3 – Israel
Societal Experts Action Network: Strategies for Communicating with People Who Are Not Vaccinated to Build Confidence in Covid-19 Vaccines | The National Academies Press
Patient Information Leaflet for Comirnaty 10 micrograms/dose concentrate (orange cap) - GOV.UK
COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022 | MMWR
Vaccinating Children with Disabilities Against COVID-19 | CDC
How to temperature map cold chain equipment and storage areas
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 | MMWR
Meningococcal Disease Outbreak, Florida, 2022 | CDC
Malaria: The malaria vaccine implementation programme (MVIP)
Peer Review Plan For 2022 Hepatitis B Screening and Testing Recs.| CDC
Video: ECDC Director on fourth doses of mRNA COVID-19 vaccines
Statement from the Council of Chief Medical Officers of Health (CCMOH) on the importance of staying up to date with COVID-19 vaccines - Canada.ca
Antibodies recognize new SARS-CoV-2 Omicron variant after booster | National Institutes of Health (NIH)
The Janssen COVID-19 Vaccine's Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events | CDC
Laboratory Testing Requirements for Vaccination with Dengvaxia Dengue Vaccine | Dengue | CDC
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Johnson & Johnson's Janssen COVID-19 Vaccine Overview and Safety | CDC
Suspension of supply of COVID-19 vaccine (COVAXIN®)
WHO supports regions to increase COVID-19 vaccination uptake among seniors, indigent population
ACIP Update to the Evidence to Recommendations for a 2nd COVID-19 Booster Dose in Adults Ages 50 Years and Older and Immunocompromised Individuals | CDC
What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents
COVID-19 vaccine update for employees: May 20, 2022 - Canada.ca
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
Cansino Ad5-nCoV-S vaccine recommendations for use
Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022
Randomized Assessment of Influenza Vaccine Efficacy Network (RAIVEN)
Hepatitis B - Vaccination of Adults | CDC
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19
The NHS influenza immunisation programme 2022 to 2023
NIH begins clinical trial evaluating second COVID-19 booster shots in adults | National Institutes of Health (NIH)
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022 | MMWR
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines
Vaccine Testing and Approval Process | CDC
COVID-19 vaccine: Canadian Immunization Guide - Canada.ca
Almost 80% of eligible over-75s receive spring booster - GOV.UK
Solidarity Trial Vaccines (STV) presentation
European Union funding boosts COVID-19 vaccination in Africa
Summary of Product Characteristics for Nuvaxovid dispersion for injection - GOV.UK
Summary of Product Characteristics for Spikevax - GOV.UK
Innovation at work: reflections from Malawi on the world's first malaria vaccine, RTS,S, in childhood vaccination
Vaccine uptake in Canadian adults 2021 - Canada.ca
Pregnant women urged to come forward for COVID-19 vaccination - GOV.UK
Patient Information Leaflet Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK
Coronavirus disease (COVID-19): Vaccines safety
COVID-19 vaccination: guide for employers - GOV.UK
Patient Information Leaflet for Spikevax - GOV.UK
Vaccine update: issue 325, April 2022, flu special edition - GOV.UK
Strengthening COVID-19 vaccine demand and uptake in refugees and migrants
Increasing Uptake of COVID-19 Vaccination Through Requirement and Incentive Programs | National Academies Press
Pfizer-BioNTech COVID-19 Vaccine Overview and Safety | CDC
Over half of pregnant women have now had one or more doses of COVID-19 vaccines - GOV.UK
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022 | MMWR
Poster: Are you and your family protected from vaccine-preventable diseases?
Press Release N°36/2021 COVID-19: The vaccine affords up to 100% protection against infections, hospitalization and death - ISS
UKHSA review shows vaccinated less likely to have long COVID than unvaccinated - GOV.UK
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know
Open to all, anytime, anywhere: Free online courses bring vaccine knowledge to the global community
Enhanced Surveillance of COVID-19 in Scotland
Vaccination requirements and recommendations for international travellers; and malaria situation per country – 2021 edition
Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits, 2nd ed
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
Weekly epidemiological record, No 47, 2021, 96, 569–584
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
International travel and health
Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014: conclusions and recommendations
COVAX No-Fault Compensation Program
COVID-19 vaccine country readiness and delivery
Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season
Behavioural considerations for acceptance and uptake of COVID-19 vaccines
Latest U.S. Flu Vaccination Coverage Estimates Continue to Show Concerning Drops in Coverage Among People at Increased Risk for Flu Complications
Use of COVID-19 Vaccines in the United States
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022
COVID-19 Vaccines
Pfizer-BioNTech COVID-19 Vaccine (Gray Cap) Age 12 and Over
Children’s vaccination rates in Scotland increased significantly during lockdown
WHO Pharmaceuticals Newsletter - N°1, 2022
Vaccination Laws
Weekly national seasonal respiratory report - WWeek ending 13 February 2022 - week 6
WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners
Adult Immunization Schedule
COVID-19 vaccines
Adult Immunization Schedule by Medical Condition and Other Indication
Child and Adolescent Immunization Schedule by Medical Indication
Measles outbreak training
Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting
Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
JCVI statement on vaccination of children aged 5 to 11 years old
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021
Vaccine Safety Basics
Malaria vaccine: WHO position paper – March 2022
Covid-19: Doctors urge government to step up on global vaccine funding
Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine (Regulation 174)
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
COVID-19 vaccination programme for children and young people: guidance for parents (version 3)
COVID-19 vaccine information and resources
WHO released a new operational guide to promote COVID-19 vaccination uptake and tackle vaccine hesitancy among refugees and migrants
Preview Posting of COVID-19 Vaccine Codes and Crosswalk for Currently Authorized Vaccines and Anticipation of Potential Vaccine Availability under Emergency Use Authorization (EUA)
COVID-19 testing, vaccination and implementation of protective measures recommended for reception centres of displaced people from Ukraine
Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
Polio vaccines: WHO position paper – March 2016
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
Selecting Viruses for the Seasonal Influenza Vaccine
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine
Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Weekly national seasonal respiratory report - Week ending 6 March 2022 - week 9
Coronavirus vaccine - weekly summary of Yellow Card reporting
COVID-19 advice for the public: Getting vaccinated
Pfizer-BioNTech Comirnaty COVID-19 vaccine
Countering the Pandemic Threat Through Global Coordination on Vaccines: The Influenza Imperative
Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines
Webinars on COVID-19
Download COVID-19 datasets
COVID-19 vaccination
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
WHO consultation on COVID-19 vaccines research - Advancing the development of pan-sarbecovirus vaccines
WHO Open Calls for Advisory Groups
Getting a COVID-19 Vaccine
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
COVID-19: Making vaccination decisions for children 5 to 11 years of age
The Global Health Observatory
